Latest news with #BroadPath
Business Standard
31-07-2025
- Business
- Business Standard
Sagility India gains after Q1 PAT soars 566% YoY to Rs 149 cr
Sagility India advanced 6.91% to Rs 45.34 after the company's consolidated net profit surged 566.49% to Rs 148.56 crore on a 25.8% jump in revenue from operations to Rs 1,538.94 crore in Q1 FY26 over Q1 FY25. Profit before tax (PBT) stood at Rs 210.39 crore in Q1 FY26, registering a surge of 196.3% compared to Rs 71.01 crore in Q1 FY25. In Q1 FY26, adjusted EBITDA stood at Rs 368.7 crore, up 26.44%, compared with Rs 291.6 crore posted in the same quarter last year. Adjusted EBITDA margin stood at 24% in Q1 FY26 as against 23.8% in Q1 FY25. In dollar terms, the company reported revenue of $180.4 million, while adjusted PAT stood at $23.4 million in Q1 FY26. As of 31st March 2025, the company had 39,917 employees. Attrition improved to 27.6% in Q1 FY26 as against 27.3% in Q1 FY25. Ramesh Gopalan, managing director and group CEO, said, Weve entered FY26 with strong momentum and confidence in our position as a leading provider of solutions and services for U.S. healthcare payers and providers. Despite ongoing regulatory and policy shifts, our business continues to demonstrate resilience and sustained growth. We are deepening engagement with both long-standing and newer clients while maintaining robust profitability. The integration of BroadPath is progressing smoothly. As our clients contend with increasing cost pressures, we are partnering with them to bring our domain and solution capabilities, along with automation and AI, to improve efficiencies and deliver better business outcomes. Sarvabhouman Srinivasan, Group Chief Financial Officer, added, We have started FY26 with a healthy revenue momentum and disciplined execution driving balanced financial performance. Margins remain stable, supported by improved delivery efficiency, cost optimization, and early gains from BroadPath integration. Cash generation continues to be robust, enabling us to fund strategic priorities and maintain financial flexibility. Our financial strategy remains focused: investing where it matters, operating efficiently, and ensuring that every growth initiative contributes to long-term value. Sagility India provides healthcare-focused, technology-enabled solutions and services primarily to U.S.-based clients in the payer and provider segments.
&w=3840&q=100)
Business Standard
31-07-2025
- Business
- Business Standard
Sagility shares jump 8% defying market weakness; why is stock in demand?
Sagility shares jumped 8.1 per cent, logging an intra-day high at ₹45.87 per share on BSE, after posting Q1 results on Wednesday, after market hours. At 11:33 AM, Sagility share price was trading 5.8 per cent higher at ₹44.87 per share on BSE. In comparison, the BSE Sensex slipped 0.45 per cent to 44.87. The market capitalisation of the company stood at ₹21,454.53 crore. The 52-week high of the company stood at ₹56.44 per share, and the 52-week low was at ₹27.02. Sagility Q1 results details In Q1, Sagility reported a 38 per cent rise in consolidated adjusted net profit at ₹199.7 crore, as compared to ₹144.7 crore a year ago. The revenue for the quarter under review stood at ₹1,538.9 crore, as compared to ₹1,223.3 crore a year ago, up 25.8 per cent. The adjusted Earnings before interest, tax, depreciation, and amortisation (Ebitda) stood at ₹368.7 crore, as compared to ₹291.6 crore year-on-year (Y-o-Y), up 26.5 per cent, and the adjusted Ebitda margin stood at 24 per cent, as compared to 23.8 per cent Y-o-Y. JM Financial Institutional Equities maintained a 'Buy' call on Sagility and raised the target price to ₹64 per share from ₹68. The brokerage also increased its earnings per share (EPS) estimates by 3-4 per cent for FY26-28. "Sagility trades at a discount to most of its listed business process outsourcing (BPO) players, despite high visibility to its earnings and 6 per cent free cash flow (FCF) yield. That is an anomaly, in our view. We value it at 30x (c.1x PEG)," the brokerage report read. Sagility management commentary Management remains reasonably confident of achieving low-to-mid teens organic growth in FY26, supported by healthy pipeline visibility, an increase in outsourcing, and a seasonally stronger H2. Including BroadPath, FY26E revenue growth could exceed 20 per cent. Notably, the outlook factors in early signs of automation-led productivity gains, with higher client volumes and continued wallet share gains expected to offset cannibalisation. Despite macro headwinds, Sagility expects over 24 per cent adjusted Ebitda margin for FY26, aided by cost discipline. The business continues to benefit from nondiscretionary demand and deeper client engagements across payer and provider segments. -Management also sees meaningful upside from mid-market penetration and newer use cases in GenAI.
